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The function of synaptic transmission and presynaptic vesicular cycle in the neuromuscular 
synapses of the diaphragm was studied in transgenic APP/PS1 mice (Alzheimer’s disease 
model). The decrease in the quantal content of end-plate potential, intense depression of the 
amplitude of terminal plate potentials under conditions of lasting high frequency stimulation 
(50 Hz), a drastic prolongation of the synaptic vesicle recycling time in APP/PS1 mice in com-
parison with wild type mice were detected. Manifest dysfunction of the neuromuscular syn-
apses, caused by disordered neurosecretion and recycling of the synaptic vesicles in the pre-
synaptic nerve endings, was detected in the Alzheimer’s disease model on transgenic APP/PS1 
mice. The study supplemented the notions on the pathogenesis of Alzheimer’s disease as a 
systemic disease, while the detected phenomena could just partially explain the development 
of motor disorders in this disease.
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Alzheimer’s disease (AD) is the most prevalent neu-
rodegenerative disease and the main cause of demen-
tia. Despite numerous studies aimed at creation of 
pharmacological and gene and cell approaches to its 
treatment, AD remains incurable. Excessive produc-
tion and accumulation in the nervous and other tissues 
of neurotoxic β-amyloid peptide (β-AP) underlies the 
disease development; the cholinergic neurons are the 
first that suffer [2,7].
Disorders in the interneuronal synaptic transmis-
sion and plasticity serve the base for cognitive disor-
ders and loss of memory in AD [7]. Synaptic dysfunc-
tion in the hippocampus and cerebral cortex in AD 
starts long before overall neuronal death, which sug-
gests considering it as a synaptic abnormality [7,10].
By the present time there are no data on the status 
of the neuromuscular synapses in AD. This problem is 
clinically significant, as patients with AD can exhibit 
motor disorders: tremor, bradykinesia, myoclonus, gait 
disorders, oculomotor disorders, etc. [3,9,12,13]. Some 
of these symptoms can be caused by the toxic effect of 
β-AP and other pathological factors on the neuromus-
cular system, which is proven by high level of β-AP in 
the patients’ skeletal muscles [4]. Previously we have 
detected disorders in the skeletal muscle contractility 
and electrogenesis on AD models [1,2,5,6].
Now we study the function of synaptic transmis-
sion and presynaptic vesicular cycle in the neuromus-
cular synapses of transgenic mice with AD model.
MATERIALS AND METHODS
Experiments were carried out on the mouse diaphragm 
neuromuscular preparations. In order to prevent con-
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